4.6 Article

GBE1 Is an Independent Prognostic Marker and Associated With CD163+ Tumor-Associated Macrophage Infiltration in Lung Adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Tumor-Associated Macrophage and Tumor-Cell Dually Transfecting Polyplexes for Efficient Interleukin-12 Cancer Gene Therapy

Nasha Qiu et al.

Summary: A novel IL12 gene-delivery vector was designed to efficiently transfect both cancer cells and TAMs, turning them into a factory for IL12 production, which effectively activates anticancer immune responses and remodels the tumor microenvironment. The intravenously administered vector slows tumor growth and doubles survival in three animal models with minimal systemic toxicities.

ADVANCED MATERIALS (2021)

Article Oncology

Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade

Shivani Srivastava et al.

Summary: CAR-T therapy shows limited efficacy in lung adenocarcinoma, but combining oxaliplatin, cyclophosphamide, and anti-PD-L1 can improve CAR-T cell infiltration into tumors and enhance efficacy.

CANCER CELL (2021)

Article Cell Biology

Dexamethasone enhances CD163 expression in porcine IPKM immortalized macrophages

Takato Takenouchi et al.

Summary: This study demonstrates that the glucocorticoid dexamethasone (DEX) can significantly enhance the expression of the CD163 receptor in IPKM cells, and this process involves the p38 MAPK signaling pathway. However, the enhanced CD163 expression induced by DEX alone is not sufficient to facilitate the infection of IPKM by PRRSV.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2021)

Article Immunology

Heme catabolism by tumor-associated macrophages controls metastasis formation

Francesca Maria Consonni et al.

Summary: This study identifies a distinct subset of TAMs with high rates of heme catabolism by HO-1, playing a critical role in shaping a prometastatic tumor microenvironment and favoring immunosuppression, angiogenesis and epithelial-to-mesenchymal transition. These TAMs originate from BM precursors, accumulate in the blood of tumor bearers, and preferentially localize at the invasive margin through Nrf2 activation and NF-kappa B1-CSF1R-C3aR axis coordination. Hindering their recruitment or deletion of HO-1 inhibits metastasis formation and enhances anticancer immunotherapy, making them a potential antimetastatic target and prognostic blood marker.

NATURE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

Khalid AbdulJabbar et al.

NATURE MEDICINE (2020)

Article Chemistry, Multidisciplinary

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

Yuqiong Xia et al.

ADVANCED MATERIALS (2020)

Review Immunology

Subsets of CD1c+DCs: Dendritic Cell Versus Monocyte Lineage

Lukas Heger et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma

Lifeng Li et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

Commensal Microbiota Promote Lung Cancer Development via γδ T Cells

Chengcheng Jin et al.

Article Cell Biology

Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer

Christopher J. Halbrook et al.

CELL METABOLISM (2019)

Article Biochemistry & Molecular Biology

Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity

Lifeng Li et al.

MOLECULAR CANCER (2019)

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

Article Oncology

Gene expression markers of Tumor Infiltrating Leukocytes

Patrick Danaher et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)

Article Oncology

The role of tumour-associated macrophages in bone metastasis

Sofia Sousa et al.

JOURNAL OF BONE ONCOLOGY (2016)

Article Critical Care Medicine

Macrophage and Cancer Cell Cross-talk via CCR2 and CX3CR1 Is a Fundamental Mechanism Driving Lung Cancer

Anja Schmall et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Gastroenterology & Hepatology

Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion

Martin Franz Sprinzl et al.

JOURNAL OF HEPATOLOGY (2015)

Article Biochemistry & Molecular Biology

The prognostic landscape of genes and infiltrating immune cells across human cancers

Andrew J. Gentles et al.

NATURE MEDICINE (2015)

Article Medicine, General & Internal

Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer

Edward B. Garon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

Systematic pan-cancer analysis of tumour purity

Dvir Aran et al.

NATURE COMMUNICATIONS (2015)

Article Multidisciplinary Sciences

Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression

Ang Yuan et al.

SCIENTIFIC REPORTS (2015)

Review Cell Biology

Hypoxia and energetic tumour metabolism

M. Christiane Brahimi-Horn et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)

Review Biochemistry & Molecular Biology

Macrophage Diversity Enhances Tumor Progression and Metastasis

Bin-Zhi Qian et al.

Article Genetics & Heredity

PrognoScan: a new database for meta-analysis of the prognostic value of genes

Hideaki Mizuno et al.

BMC MEDICAL GENOMICS (2009)

Article Immunology

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

I Kryczek et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2006)